key: cord-0900433-qe86kdu9
authors: Rahimzadeh, Poupak; Faiz, Hamid Reza; Farahmandrad, Reza; Hassanlouei, Babak; Habibi, Azadeh; Hedayati Emami, Setareh; Amniati, Saied
title: Clinical Features and Prognosis of Invasive Ventilation in Hospitalized Patients with COVID-19: A Retrospective Study
date: 2020-12-19
journal: Anesth Pain Med
DOI: 10.5812/aapm.108773
sha: d55b8b37c0895207f7c26140d958a5f4f21f7f0c
doc_id: 900433
cord_uid: qe86kdu9

BACKGROUND: World Health Organization (WHO) declared that the outbreak of COVID-19 constituted a public health emergency of global concern. OBJECTIVES: Owing to limited data on critically ill patients admitted to ICU, we aimed to describe the clinical characteristics and prognosis of these patients based on ventilatory variables and clinical features. METHODS: In this retrospective study, 45 critically ill patients with laboratory-confirmed COVID-19 who were admitted to Intensive Care Unit (ICU) wards of the hospital from April 8 to May 9, 2020, were enrolled. Medical files of the patients were reviewed, and demographic and clinical characteristics, laboratory data, lung CT scan findings, causes of intubation, and outcomes of the patients were all collected. RESULTS: The median age of the patients was 67 years (range 22 to 91), 64% were men, and hypertension was the most common comorbidity. History of close contact with previously confirmed patients was positive in 62.2% of the patients. The mean time from symptom onset to hospital admission was 5.98 ± 2.93 days. The most common symptoms at the onset of illness were dyspnea (95.6%), and gastrointestinal symptoms (22.2%) were rare. The average length of the intubation was 4.84 ± 3.28 days. The distribution of intubation causes in the deceased patients was significantly more than the recovered patients (P = 0.031). The mean score of lung CT involvement in deaths (370.26 ± 207.50) was significantly higher than the recovered patients (235.71 ± 81.21) (P = 0.042). Length of the intubation had a statistically direct correlation with respiratory rate (P = 0.03). CONCLUSIONS: Most of the critically ill patients admitted to ICU were older men and had poor outcomes with a high mortality rate. Furthermore, the score of chest CT involvement and respiratory rate are important prognostic factors in determining the severity of the illness, requiring ventilatory support, and outcome.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) is a new strain of coronavirus, which was first detected in Wuhan, China, in December 2019 (1, 2) . Thus far, coronavirus disease 2019 , caused by SARS-CoV2, has rapidly infected millions of people around the world and has become an emerging health threat (3). On February 19, 2020, Iran reported its first cases diagnosed with COVID-19 in Qom; subsequently, the increasing number of cases recorded in Qom, and finally, throughout all 31 provinces of the country (4) .

COVID-19 is a novel disease with wide clinical manifestations, encompassing asymptomatic or mild upper respiratory tract illness to severe viral pneumonia with acute respiratory distress syndrome (ARDS) and even death (5) . Whereas most infected people develop mild to moderate illness and recover without hospitalization, about 14% present with severe symptoms that require hospital care, and one-third of hospitalized patients need invasive mechanical ventilation (6) . Critically ill patients with COVID-19 may develop ARDS, septic shock, sepsis, cardiac injury, acute kidney injury, and multi-organ dysfunction (7) . Although risk factors for severe illness remain unclear, comorbidity and older age have been reported as likely important factors for poor prognosis and death (8, 9) .

To date, no specific medication or immunomodulatory therapy has yet been approved for the treatment of COVID-19, so the management of critically ill patients is similar to the management of most viral pneumonia, and supportive Copyright © 2020, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. therapy to control symptoms and to protect multi-organ function is the priority of the management (10). Therefore, due to the increase in the number of hospitalized patients and limited ICU capacity, identifying clinical characteristics and hospital course of severe and ventilated patients with COVID-19 is crucial to guide decision making regarding ICU capacities and allocation of resources to decrease the mortality rate. Most of the previous studies have just reported the general epidemiological, and clinical characteristics of hospital admitted patients with COVID-19, and there are limited data about the clinical course of severe cases of COVID-19 (7, 9, (11) (12) (13) (14) . Recently, a case series from Italy have reported detailed information on ventilatory parameters, clinical and laboratory characteristics and have determined prognosis and risk factors of ventilated patients with COVID-19 admitted to ICU. Their results showed that older age and pre-admission hypertension are the main mortality risk factors (15).

Accordingly, we aimed to describe the clinical characteristics and prognosis of critically ill patients with COVID-19 based on ventilatory variables and clinical features.

This retrospective study was done at a teaching hospital, Tehran, Iran, which is one of the referral centers for the COVID-19. The inclusion criteria were all consecutive critically ill patients with laboratory-confirmed COVID-19 who were admitted to intensive care unit (ICU) wards or transferred from wards to ICU of the hospital from April 8 to May 9, 2020. The patients without any imaging documents, either chest X-ray (CXR) or chest CT were excluded. Drug history of all enrolled cases was recorded in detail, but this information was not analyzed. All of the deaths caused by COVID-19 directly or indirectly and also caused by COVID-19 complication were recorded as COVID-19 death. Confirmed infection was defined as positive real-time polymerase chain reaction (RT-PCR) to SARS-CoV-2 in their nasopharyngeal specimens (10) . Critically ill patients were defined as intubated patients admitted to ICU who required mechanical ventilation. The respiratory rate of the patients was recorded immediately before intubation, and in case of being higher than the determined limit defined as tachypnea and the relationship between tachypnea with intubation time was then analyzed. The Ethics Commission of Iran University of Medical Sciences approved this study, and written informed consent was waived due to the nature of retrospective chart review.

Medical files of the patients were reviewed for data collection. We obtained data on demographic, signs and symptoms upon hospital admission, comorbidities, smoking history, contact exposure, history of influenza vaccination, laboratory data, lung CT scan findings, time from symptoms to hospital admission, time from hospital admission to intubation, length of the intubation, causes of intubation, and outcome data. All data were collected by two trained investigators.

Causes of intubation were classified into hypoxia and hypercapnia, hypoxia and tachypnea and hypercapnia, hypoxia and tachypnea, hypoxia, hemodynamic instability, and cardiopulmonary arrest. Hypoxia was defined as SPO 2 under 90% or PaO 2 under 60 mmHg, hypercapnia was defined as PaCO 2 above 50 mmHg, and tachypnea was defined as respiratory rate above 30/min.

Lung CT findings were graded on a scale of 1 -6 based on a classification system which had been previously evaluated in the other diseases: 1 normal; 2 ground-glass; 3 consolidation; 4 ground-glass with traction bronchiolectasis or bronchiectasis; 5 consolidation with traction bronchiolectasis or bronchiectasis, and 6 honeycombing (16, 17) . The presence of each of these abnormalities was assessed in three (upper, middle, and lower) zones of each lung. The percentage of involvement in each zone was estimated based on visual criteria by two expert radiologists. The abnormality score for each zone was calculated by multiplying the percentage area by the point value (1-6). The six-zone scores were averaged to determine the total score for each abnormality in each patient. The overall CT score for each patient was obtained by adding the six averaged scores.

All statistical analyses were performed with the Statistical Package for Social Sciences version 20.0 (SPSS Inc., Chicago, IL, USA). Means ± standard deviation (SD) and median (with an interquartile range = IQR = Q1-Q3) were used for continuous variables, and frequencies and proportions were used for categorical variables. Variables of both groups (death or survival) were compared using χ 2 tests or Fisher's Exact test for proportions and unpaired ttests for means. Pearson correlation coefficient was used to evaluate the association between characteristics with ventilatory variables. A P-value of less than 0.05 was considered statistically significant.

Fifty-four critically ill patients with confirmed COVID-19 were admitted to the ICU of the teaching hospital and we analyzed the association of clinical and laboratory variables with causes of intubation (Table 4) . Results show no statistically correlation between LDH, length of the intubation, SPO 2 , pH, and cause of intubation (P > 0.05), while respiratory rate, PaO 2 , PaCO 2 , and CT scores had a statistically direct correlation (P < 0.05). The correlation between average hospital admission to intubation time and average length of the intubation was studied with variables LDH, SPO 2 , pH, respiratory rate, PaO 2 , PaCO 2 that results showed a statistically direct correlation between average hospital admission to intubation time and PaCO 2 (P = 0.023) and a statistically direct correlation between the average length of the intubation and respiratory rate (P = 0.03). The correlation between other variables was not significant (P > 0.05) ( Table 5) .

This retrospective study describes the clinical course and outcomes of 54 critically ill patients with laboratoryconfirmed COVID-19 infection who intubated and admitted in ICU wards. As mentioned in previous studies, the population in this study mostly consisted of men (64%) and was generally older (median age, 67 years; range, 22 -91 years) than previous case series admitted to ICU in China, Italy, and America (11) (12) (13) (14) (15) . Although previous evidence suggests that older and male patients are the most susceptible individuals to COVID-19, we cannot consider older age and male gender as a risk factor for admission to the ICU or poor prognosis.

In our case series, dyspnea followed by SPO2 depression, fever, and cough were the most prevalent symptoms on admission among critically ill patients with COVID-19, which is in accordance with previous studies (18) . It seems that clinical presentations of COVID-19 are relatively similar to other betacoronavirus infections. Furthermore, less than 15% of the patients had gastrointestinal symptoms, and this was consistent with the results from other previous studies. However, the incidence of gastrointestinal symptoms in patients with MERS-CoV or SARS-CoV infection has been reported about 20% -25% (19, 20) .

In accordance with the recent reports, our study reported that 77.7% of the critically ill patients had at least one comorbidity. This is similar to what was reported by Wang et al. (72.2%), and it was 86% in another case series in the USA (13, 21) . Hypertension was the most common comorbidity in our study, this is similar to what was reported by other previous studies (18) . Moreover, the majority of the patients (62.2%) had a history of close contact with infected patients. This was concordant with the results from Bhatraju et al. (13) reported 54% had recent contact with an infected patient.

Previous studies reported a wide range of mortality rates among critically ill patients admitted to ICU, from 16% to 38%, 62%, 67%, and 80% (12) (13) (14) (15) (22) (23) (24) . In our study, overall outcomes were poor in severe patients who received ICU care, and the mortality rate (84.6%) was considerably higher than other studies. In fact, we reported the final outcomes of the patients, but previous studies just followed the patients for a limited time. Therefore, the majority of the patients were still in the ICU or hospital at the time of gathering data, and there is an underestimation in reporting mortality rate by previous studies. For example, a large Italian case series reported 26% mortality rate at 5 weeks after ICU admission; however, more than 50% of the patients were still in the ICU at the time of submission, and their outcome remains uncertain (14) . In addition, we just reported data from intubated patients and those requiring mechanical ventilation. In a case series from Wuhan, the mortality rate among critically ill patients was 62%, and it was 81% among those requiring mechanical ventilation (8) .

In agreement with the previous reports, our study confirmed that all patients had abnormal findings in chest CT scan, and bilateral multiple lobular and subsegmental areas of consolidation were the most frequent chest CT findings among ICU patients (8) . Additionally, we observed that non-survivors had a significantly higher score of lung CT involvement than survivors. This finding supports the score of chest CT involvement as a prognostic factor in outcomes of severe patients with COVID-19.

Our findings revealed that the majority of patients in this case series intubated and required mechanical ventilation because of hypoxemic, hypercapnic, and tachypneic respiratory failure. This finding supports the results of previous studies that reported respiratory failure and developed ARDS were the main reasons for intubation and ICU admission among critically ill patients with COVID-19 (15, 18) . Furthermore, respiratory rate, PaO 2 , PaCO 2 , and CT score had a statistically direct correlation with the distribution causes of intubation.

As new findings, our study demonstrated that the length of the intubation had a direct correlation with respiratory rate. In fact, the length of intubation would be longer in critically ill patients who had higher respiratory rates on admission. Therefore, we can consider the respiratory rate as a prognostic factor for the length of the intubation. This is not investigated in other studies. We can argue that the patients with higher respiratory rate have more lung involvement and greater decline in pulmonary function, so they will require mechanical ventilation and oxygen support longer than other patients.

Our study has some strong points that must be highlighted. First, the data represents certain outcomes of the patients, and the patients were fully recovered or deceased at the time of data collection. Second, we investigated the causes of intubation and scoring lung CT involvement among intubated patients as new aspects of the clinical features of critically ill patients with COVID-19. On the other hand, the small sample size and single-center study were the main limitations of the current study. Finally, we suggest that this study could be performed on a larger sample size and multicenter to clarify risk factors and prognostic factors, especially among intubated patients with COVID-19.

In summary, it was concluded that most of the critically ill patients admitted to ICU were older men and had poor outcomes with a high mortality rate. Furthermore, the score of chest CT involvement and respiratory rate are important prognostic factors in determining the severity of illness, requiring ventilatory support, and outcome. Considering the causes of intubation, especially respiratory distress among critically ill patients, the importance of earlier cardiac monitoring and ventilatory support, must be highlighted. 

A Novel Coronavirus from Patients with Pneumonia in China

Return of the Coronavirus: 2019-nCoV

World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it

Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) -China

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The Current Clinically Relevant Findings on COVID-19 Pandemic

Clinical Characteristics of Coronavirus Disease 2019 in China

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Covid-19 in Critically Ill Patients in the Seattle Region -Case Series

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in

Comparing GlideScope Video Laryngoscope and Macintosh Laryngoscope Regarding Hemodynamic Responses During Orotracheal Intubation: A Randomized Controlled Trial

Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

A major outbreak of severe acute respiratory syndrome in Hong Kong

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Clinical Characteristics of Critically Ill Patients Infected with COVID-19 in Rasoul Akram Hospital in Iran: A Single Center Study

Emergency Tracheostomy in Two Airway Trauma Patients Suspected of COVID-19: A Case Report

Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report